Wuxi Biologics (Cayman) Inc. (WXIBF)
OTHER OTC:WXIBF
Holding WXIBF?
Track your performance easily

Wuxi Biologics (Cayman) (WXIBF) Financial Statements

118 Followers

Wuxi Biologics (Cayman) Financial Overview

Wuxi Biologics (Cayman)'s market cap is currently ―. The company's EPS TTM is $0.115; its P/E ratio is 12.22; Wuxi Biologics (Cayman) is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 9.86B¥ 11.13B¥ 13.94B¥ 8.48B¥ 5.38B
Total Assets¥ 47.47B¥ 44.03B¥ 43.58B¥ 28.96B¥ 20.72B
Total Debt¥ 4.40B¥ 4.30B¥ 4.60B¥ 3.33B¥ 3.68B
Net Debt¥ -5.47B¥ -6.83B¥ -9.34B¥ -5.15B¥ -1.69B
Total Liabilities-¥ 11.33B¥ 10.00B¥ 8.06B¥ 6.95B
Stockholders Equity¥ 34.46B¥ 32.28B¥ 33.22B¥ 20.56B¥ 13.63B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Wuxi Biologics (Cayman) Earnings and Revenue History

Wuxi Biologics (Cayman) Debt to Assets

Wuxi Biologics (Cayman) Cash Flow

Wuxi Biologics (Cayman) Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis